David Stack

David (Dave) Stack has served as Pacira BioSciences, Inc.’s CEO and as a director since November 2007, and as President from November 2007 to October 2015. In June 2013, Dave was appointed as the Chairman of Pacira’s board of directors. He was a Managing Director with MPM Capital from 2005 through March 2017 and has been a Managing Partner of Stack Pharmaceuticals, Inc., a commercialization, marketing, and strategy firm, since 1998. From 2001 to 2004, he was President and CEO of The Medicines Company (Nasdaq: MDCO). Previously, Dave was President and General Manager at Innovex, Inc., and was Vice President, Business Development/Marketing at Immunomedics from 1993 until 1995. Prior to that, he was with Roche Laboratories in positions of increasing responsibility from 1981 until 1993, including Therapeutic World Leader in Infectious Disease and Director, Business Development and Planning, Infectious Disease, Oncology, and Virology.

He currently serves as a member of the board of directors of Prognos AI, Chiasma, Inc. (Nasdaq: CHMA), and Amarin Corporation plc (Nasdaq: AMRN). He was a member of the boards of directors of Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) from 2006 to 2010 and BioClinica, Inc. (Nasdaq: BIOC) from 1999 to 2010.

Dave holds a BS in pharmacy from Albany College of Pharmacy and a BS in biology from Siena College.